What was recalled
The November 2019 FDA Texas Tripe advisory covered raw frozen pet food products manufactured by Texas Tripe, Inc. (Pasadena, Texas) including ground tripe, ground turkey, ground chicken, and ground beef raw frozen pet food formulations sold in 5-pound and 20-pound tubes through specialty pet food retail and direct-to-consumer channels. The advisory covered multiple product lots based on FDA inspection sampling that detected Salmonella and/or Listeria monocytogenes in finished product. The full extent of affected production lots was not fully delineated by Texas Tripe given the absence of a voluntary recall response; the FDA advisory recommended consumers not feed any Texas Tripe raw pet food products from the contamination window pending Texas Tripe’s corrective action.
The FDA published the advisory at the FDA Recalls and Safety Alerts archive following the FDA Center for Veterinary Medicine’s inspection and sampling activity. The Texas Tripe case shared structural characteristics with the 2019 Bravo Packing Performance Dog advisory: both involved small-batch raw pet food manufacturers with FDA-detected multi-pathogen contamination, both saw the manufacturer decline voluntary recall, and both produced FDA "do not feed" advisories as the primary public communication path. The 2019 Texas Tripe and Bravo Packing events together demonstrated a recurring pattern of small-batch raw pet food producers declining voluntary recall after FDA pathogen detection.
Why it was recalled
Texas Tripe’s raw pet food production model used raw ingredient sourcing without a post-production kill step (no HPP, no cooking, no freeze-drying with validated kill parameters), relying instead on supplier qualification and environmental monitoring to manage microbial load. The 2019 FDA inspection sampling detected both Salmonella and Listeria monocytogenes in finished product, indicating the raw ingredient sourcing and/or facility environmental controls were not adequate to prevent multi-pathogen contamination. The detection of Listeria monocytogenes alongside Salmonella raised the human-handling zoonotic risk pathway profile substantially; Listeria poses elevated severe-disease risk for pregnant women, infants, the elderly, and immunocompromised adults.
The decision by Texas Tripe not to initiate a voluntary recall left the FDA with practical-options 1+2 from the FSMA mandatory-recall framework: (1) issue a public health advisory ("do not feed") to communicate risk to consumers; (2) issue a Warning Letter documenting the violation. The FDA pursued option 1 through the November 2019 advisory. The 2019 Texas Tripe case illustrates the structural limit of FDA’s voluntary-recall framework under FSMA: when a small-batch manufacturer declines voluntary recall, consumers are reliant on FDA public advisory communication rather than the more comprehensive retail-channel recall pull and direct-customer outreach that voluntary recalls trigger.
Health risks for your pet
No confirmed pet illnesses were reported at the time of the November 2019 advisory. The detection was driven by FDA inspection sampling rather than consumer illness complaints. Salmonella infection in dogs and cats presents as diarrhea (sometimes bloody), vomiting, fever, anorexia, and lethargy; severe cases produce septicemia, particularly in puppies, kittens, and immunocompromised animals. Listeria monocytogenes in pets can cause similar gastrointestinal symptoms plus, in rare cases, septicemia and CNS involvement. The dual-pathogen profile (Salmonella + Listeria across multiple lots) raised the human-handling zoonotic risk substantially. Listeria monocytogenes is particularly concerning for pregnant women (miscarriage, stillbirth, neonatal infection), infants, the elderly, and immunocompromised adults (septicemia, meningitis). Mortality in severe human listeriosis ranges 20-30%. Pets infected with Salmonella can shed bacteria in stool for weeks after clinical recovery, exposing owners through litter-box and stool-cleanup contact.
What to do if you bought affected product
The November 2019 FDA Texas Tripe advisory remains in the FDA Outbreaks and Advisories archive. Current Texas Tripe Inc. distribution status should be checked through the FDA listing and the company’s direct customer communication. If you have any Texas Tripe raw pet food products from the 2019 production window in your freezer, dispose of the product securely. Wash food bowls, prep surfaces, and hands with hot soapy water; both Salmonella and Listeria are inactivated by standard household disinfectants. Pet owners feeding any raw pet food should follow strict handling-hygiene protocols: separate cutting boards and utensils for raw pet food, immediate handwashing after handling, no cross-contamination with human food prep surfaces, and avoid raw pet food handling by pregnant women, infants, and immunocompromised household members. Pregnant women, infants, the elderly, and immunocompromised adults in households feeding raw pet food face elevated Listeria risk and should consider switching to a kill-step-included pet food format.
How this affects KibbleIQ’s grade
Texas Tripe Inc. is not in the KibbleIQ scored database — our methodology v15 covers commercial dry kibble, fresh cooked food, and selected raw-coated kibble per our published methodology. Standalone raw frozen is a distinct format that the rubric does not yet specifically score. The 2019 event is one of multiple raw pet food refused-recall cases (Bravo Packing 2019, Darwin’s 2025, Raaw Energy 2026) documented in our recall encyclopedia. Recall-history scoring under our planned methodology v2 will treat refused-recall events with substantially heavier penalty than voluntary-recall events, since the manufacturer’s response posture after pathogen detection is a quality-systems-attitude signal distinct from the underlying contamination event itself. Manufacturers that decline voluntary recall after multi-sample pathogen detection across multiple product lots demonstrate a quality-systems-attitude that warrants substantial scoring penalty under future raw-pet-food rubric design.